Aphena Pharma Solutions Invests $7M for Expansion
Leading Hospital Supply Chain Management Solution Rebrands as Syft®
Expansion areas include additional manufacturing space, custom blending suites, new liquid blending vessels and an additional high-speed bottling line
Aphena Pharma Solutions Inc. is investing in a $7 million company-wide expansion for future growth opportunities to be completed by the end of 2019. Targeted expansion areas include additional manufacturing space, custom blending suites, new liquid blending vessels and an additional high-speed bottling line.
“As Aphena continues our path towards healthcare contract service excellence and innovation, we are committed to investing in our customers’ future and earning our place as their preferred and trusted partner,” said Aphena chief executive officer, Shawn Reilley.
SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Premier
Management Health Solutions celebrates 20-year anniversary with new identity
Stratford, CT – Jan. 14, 2019 – A leading national provider of inventory control and end-to-end supply chain cost management software and services, Management Health Solutions, today celebrates its 20-year anniversary with a new brand identity as Syft®. Founded in 1999, Syft serves more than 500 hospitals in the U.S. with its supply chain automation software, clinical point-of-use solutions, inventory valuation and reconciliation services, and master data management services. With more than 400 employees across five offices worldwide, Syft performs more than 800 inventory counts per year. The re-branding marks 20 years of growth for the company and a continued commitment to solving the issue of supply waste and managing inventory spend for its customers from dock-to-doc™.
Eventus WholeHealth Announces Investment from Enhanced Healthcare Partners
Windsor, Connecticut – January 3, 2019— SCA Pharma, an FDA approved 503B sterile-compounding organization, announced today that they have been awarded a group purchasing agreement for Outsourced I.V. Admixture Services with Premier Inc.
Beginning January 1, 2019, this new agreement allows Premier members, at their discretion, access to a wide range of outsourced pharmaceuticals. SCA features an extensive product catalog containing products in the following pharmaceutical categories:
Analgesics, Anesthetics, Antiarrhythmics, Antibiotics, Anticholinergics, Anticoagulants, Antihypertensive Drugs, Diuretics, Electrolytes, Neuromuscular Blockers, Opioid Analgesics, Oxytocic Agents, Reversal Agents and Vasopressors.
SCA Pharma’s CEO Milton Boyer Addresses 8th Annual Global Healthcare Executive Summit
Pioneer in whole-health solutions for post-acute care facilities to execute on growth strategy in partnership with healthcare-focused private equity investor
CHARLOTTE, NC (Jan. 9, 2019) – Eventus WholeHealth (“Eventus” or the “Company”), a full-service, physician-led provider of interdisciplinary healthcare to individuals residing in skilled nursing and assisted living facilities, announced today that it has received an investment for growth from Enhanced Healthcare Partners (“Enhanced”), a private equity firm focused exclusively on investing in the healthcare industry.
Santa Barbara Skin Care joins the West Dermatology network
Windsor, CT - Milton Boyer, CEO of SCA Pharma, a nationally recognized FDA 503B outsourcing facility with locations in Little Rock, AK and Windsor, CT was honored to be a keynote speaker at the 8th Annual Global Healthcare Executive Summit presented by Bourne Partners which took place on October 2, 2018 in Charlotte, NC. The summit brought together executive leaders to discuss and speak on trending topics in the healthcare sector.
West Dermatology announces the latest addition to its growing network of providers – Santa Barbara Skin Care of Santa Barbara and Solvang, Calif. Owner Gary Novatt, MD, has built a practice focused on medical, surgical, and cosmetic dermatology. His team consists of Corey Frucht, MD, Robert Sheffield, MD, and Claire Wiswall, PA-C.